Jayakrishna Ambati

President at Inflammasome Therapeutics.

Earliest Form D on file: May 2026

Filed May 4, 2026

Inflammasome Therapeutics

Inflammasome inhibitor implants for geographic atrophy

Biotech, Newton MA

Signed as President

$13.2M

sold of $13.2M offered

Network

At Inflammasome Therapeutics

4 people

Balamurali K. Ambati
Executive Officer, Director
Babur Lateef
Director
Chaniyilparampu N. Ramchand
Director
Napoleone Ferrara
Director